GATTUSO, IRENE
 Distribuzione geografica
Continente #
AS - Asia 113
NA - Nord America 77
EU - Europa 75
SA - Sud America 38
AF - Africa 2
Totale 305
Nazione #
US - Stati Uniti d'America 69
SG - Singapore 44
IT - Italia 40
BR - Brasile 34
CN - Cina 31
VN - Vietnam 19
DE - Germania 13
HK - Hong Kong 6
IN - India 5
CA - Canada 4
FI - Finlandia 4
GB - Regno Unito 4
IR - Iran 4
NL - Olanda 4
FR - Francia 3
MX - Messico 3
AR - Argentina 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
BE - Belgio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ID - Indonesia 1
IQ - Iraq 1
LT - Lituania 1
SE - Svezia 1
VE - Venezuela 1
Totale 305
Città #
Singapore 21
Milan 14
Dallas 13
Ashburn 12
Beijing 8
Los Angeles 8
Hanoi 6
Hong Kong 6
Munich 6
New York 5
Hefei 4
Ho Chi Minh City 4
Santa Clara 4
Tehran 4
Amsterdam 3
Boardman 3
Melsungen 3
Shanghai 3
Vistarino 3
Assago 2
Bengaluru 2
Chennai 2
Curitiba 2
Da Nang 2
Denver 2
Frankfurt am Main 2
London 2
Mexico City 2
Montes Claros 2
Osasco 2
Phoenix 2
São Bernardo do Campo 2
São Paulo 2
Toronto 2
Turku 2
Vimodrone 2
Washington 2
Alto Paraíso de Goiás 1
Araguapaz 1
Araçatuba 1
Araçoiaba da Serra 1
Baghdad 1
Baie-D'Urfé 1
Balcarce 1
Bari 1
Bauru 1
Biên Hòa 1
Boqueirão do Leão 1
Brooklyn 1
Brussels 1
Cachoeirinha 1
Caracas 1
Cascavel 1
Caçador 1
City of London 1
Criciúma 1
Duque de Caxias 1
Helena 1
Houston 1
Ilhéus 1
Itabira 1
Itapetinga 1
Jaboticabal 1
Jiaxing 1
Johannesburg 1
Karlsruhe 1
Klerksdorp 1
Lappeenranta 1
Londrina 1
Lấp Vò 1
Macaé 1
Mendoza 1
Montreal 1
Nuremberg 1
Ourinhos 1
Paragominas 1
Phủ Lý 1
Ponta Grossa 1
Poplar 1
Primavera do Leste 1
Quanzhou 1
Querétaro 1
Quito 1
Quảng Ngãi 1
Quảng Ninh 1
Quận Bảy 1
Rieti 1
Salvador 1
Santa Bárbara d'Oeste 1
Santo Domingo 1
Seattle 1
Shenzhen 1
St Petersburg 1
Stockholm 1
Topeka 1
Três Pontas 1
Tây Ninh 1
Wilmington 1
Zhengzhou 1
Zhoukou 1
Totale 229
Nome #
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 81
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 63
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 58
Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use 50
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab 38
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study 35
Unveiling a silent threat: slowly expanding spinal cord lesion linked to clinical worsening in multiple sclerosis: a case report 2
Totale 327
Categoria #
all - tutte 1.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20239 0 0 0 0 0 0 0 0 0 0 0 9
2023/202422 0 3 0 1 5 2 1 2 0 0 3 5
2024/202572 6 0 5 1 8 2 5 6 8 2 13 16
2025/2026224 33 34 41 79 35 2 0 0 0 0 0 0
Totale 327